Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Michael Caligiuri, MD, discusses the modulation of natural killer cells to enhance their ability to detect and destroy tumor ...

A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response ...

NK cells in particular target and destroy disease-causing pathogens, and detect and control the early signs of cancer. In ANKL, the NK cells are unable to perform their usual functions.

While chemotherapy remains a cornerstone of lung cancer treatment, it often weakens the immune system it relies on for ...

Researchers are also exploring new ways to harness NK cells in cancer treatment. Clinical researcher Yago Nieto recently led a phase I/II trial evaluating a cord blood-derived NK cell therapy for ...

Results for these CAR NK cells, engineered to express interleukin-15 (IL-15), were striking: a 48.6% response rate 100 days post-treatment, a one-year overall survival rate of 68%, and no cases of ...

March 11, 2025 — 08:42 am EDT Written by None for Quiver Quantitative -> Coeptis forms GEAR Therapeutics to develop GEAR-modified NK cells for innovative cancer therapies. Quiver AI Summary ...

Researchers have discovered a way to make the immune system's T cells significantly more effective at fighting cancer. By ...